English | Español
Jamie Barrand | Oct 10, 2015

AbbVie to market hepatitis C drug Viekirax in Japan
Jamie Barrand | Oct 8, 2015

Bayer autoinjector approved by FDA for use in MS treatment
+ Technology/Innovation
Jamie Barrand | Oct 8, 2015

FDA approves Aristada to treat schizophrenia
+ Regulatory
Jamie Barrand | Oct 8, 2015

Study: Electronic health-records mandate might be impeding data-sharing goals
Jamie Barrand | Oct 7, 2015

Colorectal cancer drug approved by the FDA
+ Regulatory
Jamie Barrand | Oct 7, 2015

FDA grants Fast Track Designation for XBiotech's True Human
Jamie Barrand | Oct 7, 2015

Boehringer Ingelheim, BioMed X establish joint research team
+ Technology/Innovation
Jamie Barrand | Oct 7, 2015

Rosetta Genomics receives Notice of Allowance from U.S. Patent Office for cancer treatment

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'